Literature DB >> 7560097

Stable fetal cardiomyocyte grafts in the hearts of dystrophic mice and dogs.

G Y Koh1, M H Soonpaa, M G Klug, H P Pride, B J Cooper, D P Zipes, L J Field.   

Abstract

This report documents the formation of stable fetal cardiomyocyte grafts in the myocardium of dystrophic dogs. Preliminary experiments established that the dystrophin gene product could be used to follow the fate of engrafted cardiomyocytes in dystrophic mdx mice. Importantly, ultrastructural analyses revealed the presence of intercalated discs consisting of fascia adherens, desmosomes, and gap junctions at the donor-host cardiomyocyte border. To determine if isolated cardiomyocytes could form stable intracardiac grafts in a larger species, preparations of dissociated fetal canine cardiomyocytes were delivered into the hearts of adult CXMD (canine X-linked muscular dystrophy) dogs. CXMD dogs, like Duchenne muscular dystrophy patients and mdx mice, fail to express dystrophin in both cardiac and skeletal muscle. Engrafted fetal cardiomyocytes, identified by virtue of dystrophin immunoreactivity, were observed to be tightly juxtaposed with host cardiomyocytes as long as 10 wk after engraftment, the latest date analyzed. Confocal laser scanning microscopy revealed the presence of connexin43, a major constituent of the gap junction, at the donor-host cardiomyocyte border. The presence of intracardiac grafts was not associated with arrhythmogenesis in the CXMD model. These results indicate that fetal cardiomyocyte grafting can successfully augment cardiomyocyte number in larger animals.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7560097      PMCID: PMC185842          DOI: 10.1172/JCI118251

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  26 in total

1.  Researchers call for time out on cell-transplant research.

Authors:  L Thompson
Journal:  Science       Date:  1992-08-07       Impact factor: 47.728

Review 2.  Influence of myocardial ischemia and infarction on autonomic innervation of heart.

Authors:  D P Zipes
Journal:  Circulation       Date:  1990-10       Impact factor: 29.690

3.  The frequency of revertants in mdx mouse genetic models for Duchenne muscular dystrophy.

Authors:  I Danko; V Chapman; J A Wolff
Journal:  Pediatr Res       Date:  1992-07       Impact factor: 3.756

4.  Cell-transplant results under fire.

Authors:  L Thompson
Journal:  Science       Date:  1992-07-24       Impact factor: 47.728

Review 5.  Heterogeneity within the ventricular wall. Electrophysiology and pharmacology of epicardial, endocardial, and M cells.

Authors:  C Antzelevitch; S Sicouri; S H Litovsky; A Lukas; S C Krishnan; J M Di Diego; G A Gintant; D W Liu
Journal:  Circ Res       Date:  1991-12       Impact factor: 17.367

6.  Normal dystrophin transcripts detected in Duchenne muscular dystrophy patients after myoblast transplantation.

Authors:  E Gussoni; G K Pavlath; A M Lanctot; K R Sharma; R G Miller; L Steinman; H M Blau
Journal:  Nature       Date:  1992-04-02       Impact factor: 49.962

Review 7.  Canine X-linked muscular dystrophy as an animal model of Duchenne muscular dystrophy: a review.

Authors:  B A Valentine; N J Winand; D Pradhan; N S Moise; A de Lahunta; J N Kornegay; B J Cooper
Journal:  Am J Med Genet       Date:  1992-02-01

8.  Membrane organization of the dystrophin-glycoprotein complex.

Authors:  J M Ervasti; K P Campbell
Journal:  Cell       Date:  1991-09-20       Impact factor: 41.582

9.  Canine X-linked muscular dystrophy. An animal model of Duchenne muscular dystrophy: clinical studies.

Authors:  B A Valentine; B J Cooper; A de Lahunta; R O'Quinn; J T Blue
Journal:  J Neurol Sci       Date:  1988-12       Impact factor: 3.181

10.  Partial correction of an inherited biochemical defect of skeletal muscle by grafts of normal muscle precursor cells.

Authors:  J E Morgan; D J Watt; J C Sloper; T A Partridge
Journal:  J Neurol Sci       Date:  1988-09       Impact factor: 3.181

View more
  29 in total

Review 1.  Indispensable tools: embryonic stem cells yield insights into the human heart.

Authors:  J Hescheler; B K Fleischmann
Journal:  J Clin Invest       Date:  2001-08       Impact factor: 14.808

Review 2.  Cardiomyocyte transplantation into the failing heart-new therapeutic approach for heart failure?

Authors:  Thorsten Reffelmann; Jonathan Leor; Jochen Müller-Ehmsen; Larry Kedes; Robert A Kloner
Journal:  Heart Fail Rev       Date:  2003-07       Impact factor: 4.214

3.  Engineered fetal cardiac graft preserves its cardiomyocyte proliferation within postinfarcted myocardium and sustains cardiac function.

Authors:  Kazuro L Fujimoto; Kelly C Clause; Li J Liu; Joseph P Tinney; Shivam Verma; William R Wagner; Bradley B Keller; Kimimasa Tobita
Journal:  Tissue Eng Part A       Date:  2011-01-16       Impact factor: 3.845

4.  Genetically selected cardiomyocytes from differentiating embronic stem cells form stable intracardiac grafts.

Authors:  M G Klug; M H Soonpaa; G Y Koh; L J Field
Journal:  J Clin Invest       Date:  1996-07-01       Impact factor: 14.808

Review 5.  Cardiac repair by embryonic stem-derived cells.

Authors:  M Rubart; L J Field
Journal:  Handb Exp Pharmacol       Date:  2006

Review 6.  Cell-based approaches for cardiac repair.

Authors:  Michael Rubart; Loren J Field
Journal:  Ann N Y Acad Sci       Date:  2006-10       Impact factor: 5.691

Review 7.  Stem cell differentiation: cardiac repair.

Authors:  Michael Rubart; Loren J Field
Journal:  Cells Tissues Organs       Date:  2007-12-20       Impact factor: 2.481

8.  Molecular enhancement of porcine cardiac chronotropy.

Authors:  J M Edelberg; D T Huang; M E Josephson; R D Rosenberg
Journal:  Heart       Date:  2001-11       Impact factor: 5.994

9.  Bioreactor perfusion system for the long-term maintenance of tissue-engineered skeletal muscle organoids.

Authors:  J A Chromiak; J Shansky; C Perrone; H H Vandenburgh
Journal:  In Vitro Cell Dev Biol Anim       Date:  1998-10       Impact factor: 2.416

Review 10.  Pre-transplantation specification of stem cells to cardiac lineage for regeneration of cardiac tissue.

Authors:  Maritza Mayorga; Amanda Finan; Marc Penn
Journal:  Stem Cell Rev Rep       Date:  2009-01-30       Impact factor: 5.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.